Valério-Fernandes, Â.; Fonseca, N.A.; Gonçalves, N.; Cruz, A.F.; Pereira, M.I.; Gregório, A.C.; Moura, V.; Ladeirinha, A.F.; Alarcão, A.; Gonçalves, J.;
et al. Nucleolin Overexpression Predicts Patient Prognosis While Providing a Framework for Targeted Therapeutic Intervention in Lung Cancer. Cancers 2022, 14, 2217.
https://doi.org/10.3390/cancers14092217
AMA Style
Valério-Fernandes Â, Fonseca NA, Gonçalves N, Cruz AF, Pereira MI, Gregório AC, Moura V, Ladeirinha AF, Alarcão A, Gonçalves J,
et al. Nucleolin Overexpression Predicts Patient Prognosis While Providing a Framework for Targeted Therapeutic Intervention in Lung Cancer. Cancers. 2022; 14(9):2217.
https://doi.org/10.3390/cancers14092217
Chicago/Turabian Style
Valério-Fernandes, Ângela, Nuno A. Fonseca, Nélio Gonçalves, Ana F. Cruz, Marta I. Pereira, Ana C. Gregório, Vera Moura, Ana F. Ladeirinha, Ana Alarcão, Joana Gonçalves,
and et al. 2022. "Nucleolin Overexpression Predicts Patient Prognosis While Providing a Framework for Targeted Therapeutic Intervention in Lung Cancer" Cancers 14, no. 9: 2217.
https://doi.org/10.3390/cancers14092217
APA Style
Valério-Fernandes, Â., Fonseca, N. A., Gonçalves, N., Cruz, A. F., Pereira, M. I., Gregório, A. C., Moura, V., Ladeirinha, A. F., Alarcão, A., Gonçalves, J., Abrunhosa, A., Melo, J. B., Carvalho, L., Simões, S., & Moreira, J. N.
(2022). Nucleolin Overexpression Predicts Patient Prognosis While Providing a Framework for Targeted Therapeutic Intervention in Lung Cancer. Cancers, 14(9), 2217.
https://doi.org/10.3390/cancers14092217